X
Public Lecture
COVID-19: The Canadian Research Response
June 29, 2020
11:00 AM

Gairdner Global Perspectives Panel

Available in English and French
Monday, June 29, 2020 11AM-1PM EST

Special thanks to:

REGISTER HERE

There has been an unprecedented global scientific response to the COVID-19 pandemic. Many scientists have rapidly changed their research directions to help accelerate our understanding of the virus, to search for new treatments, to develop effective vaccines and to rapidly implement clinical trials. The societal and public health impacts of the pandemic need to be assessed and interventions tested.

The Gairdner Foundation seeks to highlight and celebrate the importance of rigorous science and global collaboration in solving major global health issues.  The Canadian government and other funders of research have recently invested considerable funding into major COVID-19 research initiatives in Canada that are contributing to the international efforts to alleviate the pandemic challenge.  This panel will explore some of these Canadian initiatives with the leaders involved. The panel will also discuss the importance of Open Science and international collaboration in promoting equitable access to public health interventions and therapies.

 

Moderator:
Janet Rossant – President & Scientific Director, The Gairdner Foundation

Welcome and Overview

Mona Nemer – Chief Scientist of Canada
Michael Strong – President, CIHR-IRSC
 

Canadian vaccine efforts

Lakshmi Krishnan – Director General, Human Health Therapeutics, National Research Council of Canada
Volker Gerdts – Director & CEO, VIDO-Intervac
Gary Kobinger – Canada Research Chair in Immunotherapy and Innovative Vaccine Platforms, Université Laval    

Audience Q&A
 

Population-wide research and impact

Rob Annan – President & CEO, Genome Canada
Catherine Hankins – Co-Chair, COVID-19 Immunity Task Force, McGill University
Carrie Bourrassa, Scientific Director, CIHR Institute of Indigenous Peoples’ Health

Audience Q&A
 

Coordination and collaboration

Guy Rouleau – Director, Montreal Neurological Institute and Hospital, McGill University & 2020 Canada Gairdner Wightman Award Laureate
Vivek Goel – Vice-President, Research and Innovation, and Strategic Initiatives, University of Toronto

Audience Q&A
 




Event Information

june, 2020

june, 2020

202029jun11:00 am- 1:00 pmCOVID-19: The Canadian Research Response11:00 am - 1:00 pm EST Event Type:Public LectureEvent Audience:Biomedical Scientists,Government,Public Event TagsCanada,COVID,Panel,Research

Event Details

Gairdner Global Perspectives Panel

Available in English and French
Monday, June 29, 2020 11AM-1PM EST

Special thanks to:

REGISTER HERE

There has been an unprecedented global scientific response to the COVID-19 pandemic. Many scientists have rapidly changed their research directions to help accelerate our understanding of the virus, to search for new treatments, to develop effective vaccines and to rapidly implement clinical trials. The societal and public health impacts of the pandemic need to be assessed and interventions tested.

The Gairdner Foundation seeks to highlight and celebrate the importance of rigorous science and global collaboration in solving major global health issues.  The Canadian government and other funders of research have recently invested considerable funding into major COVID-19 research initiatives in Canada that are contributing to the international efforts to alleviate the pandemic challenge.  This panel will explore some of these Canadian initiatives with the leaders involved. The panel will also discuss the importance of Open Science and international collaboration in promoting equitable access to public health interventions and therapies.

 

Moderator:
Janet Rossant – President & Scientific Director, The Gairdner Foundation

Welcome and Overview

Mona Nemer – Chief Scientist of Canada
Michael Strong – President, CIHR-IRSC
 

Canadian vaccine efforts

Lakshmi Krishnan – Director General, Human Health Therapeutics, National Research Council of Canada
Volker Gerdts – Director & CEO, VIDO-Intervac
Gary Kobinger – Canada Research Chair in Immunotherapy and Innovative Vaccine Platforms, Université Laval    

Audience Q&A
 

Population-wide research and impact

Rob Annan – President & CEO, Genome Canada
Catherine Hankins – Co-Chair, COVID-19 Immunity Task Force, McGill University
Carrie Bourrassa, Scientific Director, CIHR Institute of Indigenous Peoples’ Health

Audience Q&A
 

Coordination and collaboration

Guy Rouleau – Director, Montreal Neurological Institute and Hospital, McGill University & 2020 Canada Gairdner Wightman Award Laureate
Vivek Goel – Vice-President, Research and Innovation, and Strategic Initiatives, University of Toronto

Audience Q&A
 

Time

(Monday) 11:00 am - 1:00 pm

202029jun11:00 am- 1:00 pmCOVID-19: The Canadian Research Response11:00 am - 1:00 pm EST Event Type:Public LectureEvent Audience:Biomedical Scientists,Government,Public Event TagsCanada,COVID,Panel,Research

Event Details

Gairdner Global Perspectives Panel

Available in English and French
Monday, June 29, 2020 11AM-1PM EST

Special thanks to:

REGISTER HERE

There has been an unprecedented global scientific response to the COVID-19 pandemic. Many scientists have rapidly changed their research directions to help accelerate our understanding of the virus, to search for new treatments, to develop effective vaccines and to rapidly implement clinical trials. The societal and public health impacts of the pandemic need to be assessed and interventions tested.

The Gairdner Foundation seeks to highlight and celebrate the importance of rigorous science and global collaboration in solving major global health issues.  The Canadian government and other funders of research have recently invested considerable funding into major COVID-19 research initiatives in Canada that are contributing to the international efforts to alleviate the pandemic challenge.  This panel will explore some of these Canadian initiatives with the leaders involved. The panel will also discuss the importance of Open Science and international collaboration in promoting equitable access to public health interventions and therapies.

 

Moderator:
Janet Rossant – President & Scientific Director, The Gairdner Foundation

Welcome and Overview

Mona Nemer – Chief Scientist of Canada
Michael Strong – President, CIHR-IRSC
 

Canadian vaccine efforts

Lakshmi Krishnan – Director General, Human Health Therapeutics, National Research Council of Canada
Volker Gerdts – Director & CEO, VIDO-Intervac
Gary Kobinger – Canada Research Chair in Immunotherapy and Innovative Vaccine Platforms, Université Laval    

Audience Q&A
 

Population-wide research and impact

Rob Annan – President & CEO, Genome Canada
Catherine Hankins – Co-Chair, COVID-19 Immunity Task Force, McGill University
Carrie Bourrassa, Scientific Director, CIHR Institute of Indigenous Peoples’ Health

Audience Q&A
 

Coordination and collaboration

Guy Rouleau – Director, Montreal Neurological Institute and Hospital, McGill University & 2020 Canada Gairdner Wightman Award Laureate
Vivek Goel – Vice-President, Research and Innovation, and Strategic Initiatives, University of Toronto

Audience Q&A
 

Time

(Monday) 11:00 am - 1:00 pm




X
X